HuangJLiYTangY. CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke2013; 44:190–7.
2.
KalatskayaIBerchicheYAGravelS. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol2009; 75:1240–7.
3.
Ramos-CejudoJGutiérrez-FernándezMRodríguez-FrutosB. Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis. PLoS ONE2012; 7:e52121.
4.
MerinoJJGutiérrezMRodríguez-FrutosBAlvarez-GrechJ. CXCR4/SDF-1α-chemokine regulates neurogenesis and/or angiogenesis within the vascular niche of ischemic rats; however, does SDF-1α play a role in repair?Int J Stroke2011; 6:466–7.
5.
LiuSJiaXLiC. CXCR7 Silencing Attenuates Cell Adaptive Response to Stromal Cell Derived Factor 1α after Hypoxia. PLoS ONE2013; 8:e55290.
6.
ZhuBXuDDengX. CXCL12 enhances human neural progenitor cell survival through a CXCR7- and CXCR4-mediated endocytotic signaling pathway. Stem Cells2012; 30:2571–83.
